![Hui Ping Wu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hui Ping Wu
Directeur/Bestuurslid bij XinYu Pharmaceutical Co., Ltd.
Actieve functies van Hui Ping Wu
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
XinYu Pharmaceutical Co., Ltd.
![]() XinYu Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Xinyu Pharmaceutical Co., Ltd. engages in the research, development, and production of microbial pharmaceuticals. Its key products are the active pharmaceutical ingredient lincomycin hydrochlorlde and its derivatives, which include clindamycin hydrochloride and clindamycin phosphate, as well as neomycin sulphate, moxidectin, framycetin sulphate, tenofovir disoproxil fumarate, nosihepitde premix, and enramycin premix. The company was founded in 1988 and is headquartered in Suzhou, China. | Directeur/Bestuurslid | 01-12-2016 | - |
Independent Dir/Board Member | 01-12-2016 | - |
Loopbaan van Hui Ping Wu
Eerdere bekende functies van Hui Ping Wu
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
SHANGHAI TONGDA VENTURE CAPITAL CO., LTD. | Directeur/Bestuurslid | 21-06-2012 | - |
Independent Dir/Board Member | 21-06-2012 | - |
Statistieken
Internationaal
China | 3 |
Operationeel
Director/Board Member | 2 |
Independent Dir/Board Member | 2 |
Sectoraal
Finance | 2 |
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
SHANGHAI TONGDA VENTURE CAPITAL CO., LTD. | Finance |
Bedrijven in privébezit | 1 |
---|---|
XinYu Pharmaceutical Co., Ltd.
![]() XinYu Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Xinyu Pharmaceutical Co., Ltd. engages in the research, development, and production of microbial pharmaceuticals. Its key products are the active pharmaceutical ingredient lincomycin hydrochlorlde and its derivatives, which include clindamycin hydrochloride and clindamycin phosphate, as well as neomycin sulphate, moxidectin, framycetin sulphate, tenofovir disoproxil fumarate, nosihepitde premix, and enramycin premix. The company was founded in 1988 and is headquartered in Suzhou, China. | Health Technology |
- Beurs
- Insiders
- Hui Ping Wu
- Ervaring